BTL ULTRA FEMME 360°
WHAT CAN WE TREAT?
We are proud to be the first centre in Continental Europe to offer treatment with the BTL Ultra Woman 360°, an innovative and non-invasive technology using radio frequency, which provides vaginal rejuvenation and lip reshaping (reduction in the size of the lips).
The heat provided by the radiofrequency stimulates the production of collagen.
The BTL Ultra Female 360 is used for:
- Vaginal firming
- Firming of the Lips
BTL Ultra Female 360, is an innovative and non-invasive technology, using radio frequency, which allows for vaginal rejuvenation and lip reshaping (reduction in the size of the lips). The heat provided by the radiofrequency stimulates the production of collagen.
BTL ULTRA FEMME 360°
WHAT YOU NEED TO KNOW
TREATMENT DESCRIPTION
This treatment firms the tissue while reducing the diameter of the vaginal opening and canal. It improves sensations, the natural lubrication of the vagina, and the quality of orgasm. It also reduces stress urinary incontinence, a common complaint in young and older patients, especially after one or more births.
The treatment is carried out by a female therapist; the patient is placed on her back, a gel is applied but no anaesthesia is necessary.
ANESTHESIA
The patient is placed on her back, a gel is applied but no anaesthesia is required.
TREATMENT DURATION
The session lasts 8 minutes for the treatment of the vaginal canal and about 12 minutes if necessary for the treatment of the vestibule, labia majora and perineum.
NUMBER OF SESSIONS
3 to 4 treatment sessions are necessary, 7 days apart.
SIDE EFFECTS
Patients feel a pleasant warm sensation, but there is no pain. Redness and slight oedema may be noticed, which disappears a few hours after treatment. There is no social eviction. It is recommended to abstain from sexual intercourse during the week following the treatment.
RESULTS
Patients can already observe an improvement after the first session (50% of the desired result) but significant results are obtained as early as the 4th week after the end of the treatment cycle.